Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole vs Famotidine for Recurrent Idiopathic Ulcer Bleeding
NCT01180179Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2010
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lansoprazole in peptic ulcer disease (PUD) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Recurrent ulcer bleeding at 24 months. Started Jun 2010; status: completed.
02
Drugs
lansoprazole
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT01180179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180179.